55 tracked 13F filers disclose a position in PMVP as of the latest SEC 13F filings, a combined $30.2M in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Position value | Shares | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | TANG CAPITAL MANAGEMENT LLC | $5.3M | 4.2M | ▼−14% Reduced · −695K sh | Q1 2026 | |
| 2 | ArrowMark Colorado Holdings LLC | $3.6M | 2.9M | ▼−7.0% Reduced · −217K sh | Q1 2026 | |
| 3 | Euclidean Capital LLC | $3.3M | 2.6M | —Held | Q1 2026 | |
| 4 | Eversept Partners, LP | $2.9M | 2.3M | ▲New +2.3M sh | Q1 2026 | |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | $2.4M | 2.0M | →First observed position No prior filed position | Q1 2026 | |
| 6 | TWO SIGMA INVESTMENTS, LP | $2.3M | 1.9M | ▲+167% Added · +1.2M sh | Q1 2026 | |
| 7 | ADAGE CAPITAL PARTNERS GP, L.L.C. | $2.3M | 1.9M | ▲New +1.9M sh | Q1 2026 | |
| 8 | BlackRock, Inc. | $1.1M | 874K | ▼−20% Reduced · −221K sh | Q1 2026 | |
| 9 | MORGAN STANLEY | $1.1M | 864K | ▲+774% Added · +765K sh | Q1 2026 | |
| 10 | Longaeva Partners L.P. | $685K | 552K | ▲New +552K sh | Q1 2026 | |
| 11 | GEODE CAPITAL MANAGEMENT, LLC | $615K | 496K | ▲+11% Added · +50K sh | Q1 2026 | |
| 12 | MARSHALL WACE, LLP | $538K | 434K | ▼−6.7% Reduced · −31K sh | Q1 2026 | |
| 13 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | $532K | 429K | —Held | Q1 2026 | |
| 14 | Walleye Capital LLC | $416K | 336K | —Held | Q1 2026 | |
| 15 | VANGUARD FIDUCIARY TRUST CO | $370K | 298K | →First observed position No prior filed position | Q1 2026 | |
| 16 | BANK OF AMERICA CORP /DE/ | $298K | 241K | ▲+0.2% Added · +393 sh | Q1 2026 | |
| 17 | ADAR1 Capital Management, LLC | $286K | 231K | ▲+129% Added · +130K sh | Q1 2026 | |
| 18 | STATE STREET CORP | $227K | 183K | —Held | Q1 2026 | |
| 19 | JACOBS LEVY EQUITY MANAGEMENT, INC | $223K | 180K | ▼−66% Reduced · −344K sh | Q1 2026 | |
| 20 | EVOKE WEALTH, LLC | $165K | 133K | —Held | Q1 2026 | |
| 21 | JANE STREET GROUP, LLC | $154K | 124K | ▼−75% Reduced · −375K sh | Q1 2026 | |
| 22 | BIT Capital GmbH | $153K | 124K | ▲New +124K sh | Q1 2026 | |
| 23 | NORTHERN TRUST CORP | $143K | 115K | ▼−70% Reduced · −267K sh | Q1 2026 | |
| 24 | GOLDMAN SACHS GROUP INC | $142K | 115K | ▼−9.6% Reduced · −12K sh | Q1 2026 | |
| 25 | Ikarian Capital, LLC | $111K | 89K | —Held | Q1 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
Last quarter, 6 funds opened a new position in PMVP and 6 added to an existing one, while 8 reduced and 0 exited entirely — based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).
| Company | Co-held by | Combined value |
|---|---|---|
| ELI LILLY & COLLY | 16 funds | $1.3B |
| BRISTOL-MYERS SQUIBB COBMY | 16 funds | $376.1M |
| AMAZON.COM INCAMZN | 15 funds | $5.6B |
| MICROSOFT CORPMSFT | 15 funds | $4.5B |
| COSTCO WHOLESALE CORPCOST | 15 funds | $1.4B |
| CHEVRON CORPCVX | 15 funds | $1.3B |
| BANK OF AMERICA CORPBAC | 15 funds | $749.2M |
| SCHWAB (CHARLES) CORPSCHW | 15 funds | $559.2M |
| REGENERON PHARMACEUTICALSREGN | 15 funds | $313.9M |
| NVIDIA CORPNVDA | 14 funds | $9.8B |
| BROADCOM INCAVGO | 14 funds | $3.0B |
| META PLATFORMS INC-CLASS AMETA | 14 funds | $3.0B |
Ranked by how many of PMVP's institutional holders also hold each name, a cross-fund conviction signal.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Oct 23, 2025 | OrbiMed Capital GP V LLC | 10% Owner | Sell (S) | 1.0M | $1.5M |
| Sep 10, 2025 | ORBIMED ADVISORS LLC | 10% Owner | Sell (S) | 500K | $900K |
| Jul 1, 2025 | Mack David Henry | President and CEO, Director | Sell (S) | 58K | $62K |
| Jul 1, 2025 | Carulli Michael | Chief Financial Officer | Sell (S) | 28K | $30K |
| Jul 1, 2025 | Jalota Deepika | Chief Development Officer | Sell (S) | 33K | $35K |
| Jul 1, 2025 | Ticktin Robert | General Counsel & COO | Sell (S) | 23K | $25K |
| Sep 11, 2024 | Carulli Michael | Chief Financial Officer | Sell (S) | 3K | $4K |
| Sep 11, 2024 | Jalota Deepika | Chief Development Officer | Sell (S) | 7K | $11K |
| Nov 22, 2023 | OrbiMed Genesis GP LLC | 10% Owner | Sell (S) | 88K | $196K |
| Sep 15, 2023 | Alland Leila | Chief Medical Officer | Sell (S) | 6K | $42K |
| Sep 15, 2023 | Jalota Deepika | Chief Development Officer | Sell (S) | 4K | $27K |
| May 26, 2022 | OrbiMed Capital GP V LLC | 10% Owner | Sell (S) | 26K | $418K |
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/PMVP/capital-change-brief"
Use Arkolith's capital_change_brief for PMVP. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for PMVP. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.